School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
J Oral Pathol Med. 2017 Nov;46(10):1040-1045. doi: 10.1111/jop.12570. Epub 2017 Apr 6.
Oral submucous fibrosis (OSF) is one of the well-recognized oral potentially malignant disorders. In this study, we investigated the malignant transformation of OSF in a Taiwanese population.
A retrospective cohort study was analyzed from Taiwan's National Health Insurance Research Database. A comparison cohort was randomly frequency-matched with the OSF cohort according to age, sex, and index year. Oral leukoplakia (OL) was further stratified to evaluate for the possible synergistic effects of OSF-associated malignant transformation.
In this cohort, 71 (9.13%) of 778 cases of OSF were observed to transform into oral cancer. The malignant transformation rate was 29.26-fold in the OSF cohort than in the comparison cohort after adjustment (95% confidence intervals 20.55-41.67). To further stratify with OL, OSF with OL (52.46%; 95% confidence intervals 34.88-78.91) had higher risk of malignant transformation rate than OSF alone (29.84%; 95% confidence intervals 20.99-42.42). The Kaplan-Meier plot revealed the rate free of malignant transformation was significant over the 13-year follow-up period (log-rank test, P<.001). The mean duration of malignant transformation was 5.1, 2.7, and 2.2 years for non-OSF, OSF alone, and OSF with OL, respectively.
Oral submucous fibrosis patients exhibited a significantly higher risk of malignant transformation than those without OSF. OL could enhance malignant transformation in patients with OSF.
口腔黏膜下纤维性变(OSF)是一种公认的口腔潜在恶性疾病。本研究旨在调查台湾人群中 OSF 的恶性转化情况。
本研究采用回顾性队列研究,对台湾全民健康保险研究数据库进行分析。根据年龄、性别和索引年度,对 OSF 队列进行随机频率匹配,以建立对照组。进一步对口腔白斑(OL)进行分层,以评估 OSF 相关恶性转化的可能协同作用。
本队列中,71 例(9.13%)778 例 OSF 病例观察到转化为口腔癌。调整后,OSF 队列的恶性转化率是对照组的 29.26 倍(95%置信区间 20.55-41.67)。为进一步进行 OL 分层,OSF 伴 OL(52.46%;95%置信区间 34.88-78.91)的恶性转化率高于单纯 OSF(29.84%;95%置信区间 20.99-42.42)。Kaplan-Meier 图显示,在 13 年的随访期间,无恶性转化的患者比例有显著差异(对数秩检验,P<.001)。非 OSF、单纯 OSF 和 OSF 伴 OL 患者的恶性转化平均持续时间分别为 5.1、2.7 和 2.2 年。
与无 OSF 的患者相比,OSF 患者发生恶性转化的风险显著更高。OL 可增强 OSF 患者的恶性转化。